ES2101747T3 - Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1. - Google Patents

Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.

Info

Publication number
ES2101747T3
ES2101747T3 ES91912424T ES91912424T ES2101747T3 ES 2101747 T3 ES2101747 T3 ES 2101747T3 ES 91912424 T ES91912424 T ES 91912424T ES 91912424 T ES91912424 T ES 91912424T ES 2101747 T3 ES2101747 T3 ES 2101747T3
Authority
ES
Spain
Prior art keywords
treatment
infections
penciclovir
famciclovir
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912424T
Other languages
English (en)
Inventor
M D J Kenig
Hodge R A Vere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2101747T3 publication Critical patent/ES2101747T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE UN DERIVADO DE GUANINA O DE UN PROMEDICAMENTO DEL MISMO PARA EL TRATAMIENTO DE INFECCIONES VIRALES.
ES91912424T 1990-07-07 1991-07-03 Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1. Expired - Lifetime ES2101747T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015051A GB9015051D0 (en) 1990-07-07 1990-07-07 Pharmaceutical treatment

Publications (1)

Publication Number Publication Date
ES2101747T3 true ES2101747T3 (es) 1997-07-16

Family

ID=10678814

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912424T Expired - Lifetime ES2101747T3 (es) 1990-07-07 1991-07-03 Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.

Country Status (17)

Country Link
EP (1) EP0538305B1 (es)
JP (1) JP2764656B2 (es)
KR (1) KR100196339B1 (es)
AP (1) AP291A (es)
AT (1) ATE151291T1 (es)
AU (1) AU647807B2 (es)
CA (1) CA2086756C (es)
DE (1) DE69125610T2 (es)
DK (1) DK0538305T3 (es)
ES (1) ES2101747T3 (es)
GB (1) GB9015051D0 (es)
GR (1) GR3023611T3 (es)
HK (1) HK1004527A1 (es)
IE (1) IE912358A1 (es)
IL (1) IL98749A (es)
WO (1) WO1992000742A1 (es)
ZA (1) ZA915214B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
GB9323403D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
US6683084B1 (en) 1993-11-12 2004-01-27 Novartis International Pharmaceutical Ltd. Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
KR100382707B1 (ko) * 1994-12-12 2003-08-19 노파르티스 인터내셔널 파마슈티칼 리미티드 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
GB9504497D0 (en) 1995-03-07 1995-04-26 Smithkline Beecham Plc Pharmaceuticals
DE69629188T2 (de) * 1995-04-24 2004-04-22 Novartis International Pharmaceutical Ltd. Verwendung von (r)-penciclovirtriphosphat zur herstellung eines arzneimittels zur behandlung von viruserkrankungen
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
DE3730541A1 (de) * 1987-09-11 1989-04-06 Hoechst Ag Verwendung bestimmter 6-mercaptopurine zur herstellung eines arzneimittels sowie verfahren zur herstellung des arzneimittels
AT388500B (de) * 1987-10-27 1989-06-26 Wellcome Found Antivirale 8-phenylxanthine

Also Published As

Publication number Publication date
DE69125610T2 (de) 1997-11-20
CA2086756A1 (en) 1992-01-08
GR3023611T3 (en) 1997-08-29
AU8103291A (en) 1992-02-04
HK1004527A1 (en) 1998-11-27
EP0538305B1 (en) 1997-04-09
AP291A (en) 1993-12-29
CA2086756C (en) 2003-04-08
KR100196339B1 (ko) 1999-06-15
ATE151291T1 (de) 1997-04-15
DE69125610D1 (de) 1997-05-15
WO1992000742A1 (en) 1992-01-23
JP2764656B2 (ja) 1998-06-11
DK0538305T3 (da) 1997-10-13
EP0538305A1 (en) 1993-04-28
AP9100290A0 (en) 1991-07-31
IE912358A1 (en) 1992-01-15
JPH05507719A (ja) 1993-11-04
GB9015051D0 (en) 1990-08-29
IL98749A (en) 1995-03-30
AU647807B2 (en) 1994-03-31
IL98749A0 (en) 1992-07-15
ZA915214B (en) 1992-06-24

Similar Documents

Publication Publication Date Title
DE69230140T2 (de) Antivirale nucleosidkombination
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
AR015940A1 (es) Derivados de rapamicina que contiene tetrazol con vidas medias acortadas y su uso para la manufactura de un medicamento
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
FI862011A0 (fi) Terapeutiska nukleosider.
MX9200361A (es) Nuevo uso del antagonista de adenosina.
ZA913033B (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic basis,their preparation and use
MX9201546A (es) Compuestos utiles para el tratamiento del vih y otros retrovirus.
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
DE68900760D1 (de) Virushemmende nukleosidmischung.
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
IT1239064B (it) Uso terapeutico del dipiridamolo
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.
NO912382L (no) Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse.
ES2153854T3 (es) Uso de compuestos de triazina para el tratamiento de trastornos de la memoria y del aprendizaje.
ES2169116T3 (es) Uso de los derivados de 2-amino purina en el tratamiento y profilaxis del virus 6 del herpes humano.
IT1219938B (it) Impiego farmaceutico del dietila-minoetil-destrano
CO4790095A1 (es) Derivados de tienoxacinona inhibodores de la proteasa del herpes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 538305

Country of ref document: ES